Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
- Brent Pfeiffenberger, Pharm.D., MBA, appointed Chief Executive Officer of Century Therapeutics - - Initial data from the ongoing Phase...
Read more
HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Reported positive preliminary Phase 2 data on additional patients for HB-200 in combination with pembrolizumab in the 1st-line setting for advanced...
Read moreOne to Watch: WorkTech Puts Crosschq at the Forefront of Industry Innovation
Hiring Intelligence Leader Highlighted on WorkTech’s 2023 Companies to Watch List of Tech Providers Crosschq named 2023 Company to Watch...
Read moreOmega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
Announced promising preliminary clinical data for OTX-2002 from ongoing MYCHELANGELO™ I trial; clinical proof-of-platform established with potential applicability across a...
Read moreOklahoma County Sheriff’s Office to Conduct First-Ever Online Foreclosure Auction with Bid4Assets.com
Oklahoma County’s first internet-based sheriff's sale is scheduled for November 14OKLAHOMA CITY, Nov. 09, 2023 (GLOBE NEWSWIRE) -- The Oklahoma...
Read moreNew Era Helium Corp’s Announces Helium Tolling and Crude Helium Purchase Agreements
MIDLAND, Texas, Nov. 09, 2023 (GLOBE NEWSWIRE) -- NEH Midstream LLC (“NEH” or the “Company”), a wholly owned subsidiary of...
Read moreCabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
– Initial clinical data from CABA-201 treated patients in Phase 1/2 trials for lupus and/or myositis expected in the first...
Read moreCentury Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory Diseases
PHILADELPHIA and MADISON, Wis., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (NASDAQ: IPSC), an innovative clinical-stage biotechnology company...
Read moreAvalo Reports Third Quarter 2023 Financial Results and Provides Business Updates
Successfully eliminated $35 million debt paving the way for future growth and innovationDivested AVTX-800 series for potential milestone payments of...
Read moreGood Supply™ Cannabis Launches ‘Get Blitzen’d’ Holiday Campaign and New Limited-Edition Products Across Canada
Ignite this Year’s Holiday Festivities with Good Supply’s ‘Holiday Helper’ 36 Pre-Roll Mix Pack and ‘The Grump’ MONSTERS 1000mg Infused...
Read moreADVERTISEMENTS
Shortcodes Ultimate
ADVERTISEMENTS
